We are live on ! Find out more
LOM

Loeb Offshore Management Portfolio holdings

AUM $547M
1-Year Est. Return 50.11%
This Fund
S&P 500
This Quarter Est. Return
+16.42%
1 Year Est. Return
+50.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$324M
AUM Growth
+$128M
Cap. Flow
+$142M
Cap. Flow %
43.72%
Top 10 Hldgs %
19.35%
Holding
287
New
144
Increased
61
Reduced
24
Closed
54

Sector Composition

Rank Sector Weight
1 Financials 11.59%
2 Technology 10.88%
3 Healthcare 10.66%
4 Communication Services 8.91%
5 Consumer Discretionary 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBYI icon
176
Puma Biotechnology
PBYI
$406M
$239K 0.07%
+4,460
New +$240K
SLXP
177
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$238K 0.07%
+3,553
New +$245K
HEOP
178
DELISTED
Heritage Oaks Bancorp
HEOP
$235K 0.07%
36,700
-42,000
-53% -$272K
OCR
179
DELISTED
OMNICARE INC
OCR
$234K 0.07%
+4,217
New +$225K
DVA icon
180
DaVita
DVA
$15.4B
$231K 0.07%
+4,060
New +$233K
CBST
181
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$231K 0.07%
+3,633
New +$220K
SPY icon
182
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$227K 0.07%
30,400
+11,400
+60% +$1.91M
QLTI
183
DELISTED
QLT Inc
QLTI
$222K 0.07%
47,927
+22,927
+92% +$99.5K
SCMP
184
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$221K 0.07%
+35,489
New +$222K
SNDA icon
185
Sonida Senior Living
SNDA
$2.04B
$218K 0.07%
+686
New +$233K
MTEM
186
DELISTED
Molecular Templates, Inc.
MTEM
$215K 0.07%
+280
New +$230K
INVA icon
187
Innoviva
INVA
$1.61B
$210K 0.06%
+6,371
New +$198K
ENTA icon
188
Enanta Pharmaceuticals
ENTA
$367M
$209K 0.06%
+9,104
New +$174K
MDCO
189
DELISTED
Medicines Co
MDCO
$207K 0.06%
+6,161
New +$196K
MCK icon
190
McKesson
MCK
$104B
$206K 0.06%
1,609
-891
-36% -$109K
ABT icon
191
Abbott
ABT
$187B
$205K 0.06%
+6,190
New +$217K
ZTS icon
192
Zoetis
ZTS
$32.5B
$205K 0.06%
+6,598
New +$202K
NPSP
193
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$205K 0.06%
+6,434
New +$148K
FURX
194
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$205K 0.06%
+4,661
New +$193K
KERX
195
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$196K 0.06%
19,431
+9,431
+94% +$83.9K
UNH icon
196
CALL
UnitedHealth
UNH
$389B
$193K 0.06%
+75,000
New +$5.37M
CIS
197
DELISTED
CAMELOT INFORMATION SYSTEMS INC ADS (EA RSTG 4 ORD)
CIS
$190K 0.06%
+99,999
New +$177K
MRGE
198
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$186K 0.06%
+71,270
New +$239K
OREX
199
DELISTED
Orexigen Therapeutics, Inc.
OREX
$183K 0.06%
+2,983
New +$202K
DRTX
200
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$177K 0.05%
19,621
+4,621
+31% +$38.3K

Similar funds

Loeb Offshore Management's Q3 2013 Portfolio in Review

As of Q3 2013, Loeb Offshore Management held 287 positions worth $324M, up 66% from $196M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Loeb Offshore Management deployed $142M of net new capital in Q3 2013, opening 144 new positions and adding to 61 existing holdings. Its largest new stake was Vodafone: 170,988 shares worth $6.13M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 6.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Viacom Inc. Class B, an estimated $6.94M trimmed.

  • Loeb Offshore Management's largest Q3 2013 buy was Vodafone: 170,988 shares worth $6.13M.
  • Loeb Offshore Management added most to MetLife in Q3 2013, an estimated $7.8M increase.
  • Loeb Offshore Management's biggest Q3 2013 reduction was Viacom Inc. Class B, cutting an estimated $6.94M.
  • Loeb Offshore Management fully exited Cooper Tire & Rubber Co. in Q3 2013, selling an estimated $7.13M.
  • Loeb Offshore Management's ten largest holdings make up 19% of its $324M portfolio in Q3 2013.
  • Loeb Offshore Management opened 144 new positions and closed 54 in Q3 2013.
  • Loeb Offshore Management's portfolio value rose 66% quarter-over-quarter to $324M.

Based on Loeb Offshore Management's 13F filing for Q3 2013, filed 14 Nov 2013.